Calver Pang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Thomas Wild | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Thomas Wild | Medicine and Dentistry | Best Researcher Award

Senoir Consultant at Praxis Dr. Thomas Wild, Germany

Dr. Thomas Wild is a highly accomplished researcher with 157 original papers (impact factor 196.5), a book published by Springer Verlag, 13 book chapters, and 182 abstracts. His contributions to wound healing, dermatology, plastic surgery, and immunology are further demonstrated through 3 patents (2 EU, 1 US) and 4 consensus papers. As Medical Director of multiple wound healing academies and a leading educator at the University of Applied Science Anhalt, he has significantly influenced medical education. With 324 lectures at national and international congresses, his global impact is evident. While his extensive research and leadership make him a strong candidate for the Best Researcher Award, highlighting research grants, international collaborations, and public engagement could further strengthen his case. Overall, his innovative work, academic contributions, and clinical expertise establish him as a leading figure in medical research, making him highly deserving of this recognition.

Professional Profile 

Education

Dr. Thomas Wild pursued his education in human medicine, beginning at the University of Leipzig from 1990 to 1994 before continuing at the University of Vienna, where he graduated in 1998. His academic journey provided a strong foundation in surgery, with extensive hands-on experience across multiple specialties, including cardiac, vascular, transplantation, and pediatric surgery. Over the years, he expanded his expertise through continuous education and research, contributing significantly to wound healing, dermatology, plastic, and aesthetic surgery. Currently, he plays a pivotal role in medical education as the Head of the “Academic Wound Consultant” course at the University of Applied Science Anhalt and holds key academic positions at renowned institutions, including the Medical University Halle and the Medical University Theodor Fontane. His commitment to lifelong learning and knowledge dissemination has made him a leader in medical education and research, shaping the next generation of healthcare professionals.

Professional Experience

Dr. Thomas Wild has an extensive professional career spanning over two decades, specializing in surgery, wound healing, dermatology, and plastic and aesthetic surgery. He began as a scientific assistant in various surgical departments at the University of Vienna, gaining expertise in cardiac, vascular, transplantation, and pediatric surgery. He later became a staff member in general surgery, focusing on mammary, liver, gallbladder, and pancreatic procedures. His leadership roles include serving as the Medical Director of the Academy of Wound Technology in Paris and the German Wound Academy. He also directed nine German wound healing centers and contributed to dermatology and immunology research. Since 2021, he has led plastic, hand, and aesthetic surgery at the BG Clinic Bergmannstrost in Halle (Saale), Germany, while also holding academic roles at the University of Applied Science Anhalt and Medical University Theodor Fontane. His expertise and leadership have significantly advanced surgical and wound healing research.

Research Interest

Dr. Thomas Wild’s research interests focus on wound healing, dermatology, plastic and aesthetic surgery, immunology, and vascular surgery. His work emphasizes innovative treatment approaches, including advanced wound care techniques, regenerative medicine, and surgical interventions to improve patient outcomes. He has made significant contributions through 157 original research papers, multiple book chapters, and patents, showcasing his commitment to developing new medical solutions. His expertise extends to translational research, bridging the gap between laboratory findings and clinical applications. As a leader in wound management, he has played a crucial role in shaping international guidelines and best practices through consensus papers. Additionally, his involvement in medical education ensures the dissemination of cutting-edge research to the next generation of healthcare professionals. His multidisciplinary approach, combining clinical practice with scientific inquiry, has positioned him as a key figure in advancing modern surgical techniques and improving patient care in complex medical conditions.

Award and Honor

Dr. Thomas Wild has received numerous awards and honors in recognition of his outstanding contributions to medical research, surgery, and wound healing. His pioneering work in dermatology, plastic surgery, and immunology has earned him prestigious accolades from leading medical institutions and professional organizations. With 157 original research papers, multiple patents, and a Springer Verlag-published book, his impact on medical science has been widely acknowledged. As the Medical Director of the Academy of Wound Technology and the German Wound Academy, he has played a significant role in advancing wound care practices. His leadership in medical education and research has also been recognized through academic appointments at top universities, including the University of Applied Science Anhalt and the Medical University Theodor Fontane. Through his extensive contributions to surgical advancements and patient care, Dr. Wild has cemented his reputation as a leading expert in his field, earning international acclaim and professional recognition.

Research Skill

Dr. Thomas Wild possesses exceptional research skills, demonstrated through his extensive contributions to wound healing, dermatology, plastic surgery, and immunology. His ability to conduct high-impact research is evident in his 157 original publications, multiple book chapters, and patents, showcasing his innovative approach to medical science. He excels in clinical research, translational medicine, and the development of advanced wound care techniques, bridging the gap between laboratory discoveries and real-world applications. His analytical skills, combined with a deep understanding of surgical procedures and patient care, enable him to develop evidence-based solutions for complex medical challenges. Additionally, his expertise in publishing, grant writing, and leading research teams has contributed to the advancement of international medical guidelines. As an academic leader, he plays a crucial role in mentoring young researchers and shaping the future of medical education. His multidisciplinary approach and commitment to innovation make him a leading figure in medical research.

Conclusion

Dr. Thomas Wild is a highly suitable candidate for the Best Researcher Award, given his outstanding contributions to wound healing, dermatology, and plastic surgery. His impressive research output, leadership in medical education, and innovative patents make him a strong contender. Strengthening details on funding, international collaborations, and public engagement could further solidify his case. Overall, his work has had a significant impact on the field, making him a deserving candidate for the award.

Publications Top Noted

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Tawfick, W.A., Wild, T. (2024). Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus. Journal of Tissue Viability

  • Wild, T., Aljowder, A.A., AlJawder, A.A.A., Marotz, J., Siemers, F. From Wound to Scar: Scarring Explained—Pathophysiology of Wound Healing. [Book Chapter] – 1 Citation

  • Traber, J., Wild, T., Marotz, J., Berli, M.C., Franco-Obregón, A. (2023). Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series. Bioengineering – 6 Citations

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2023). Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types. Wounds – 1 Citation

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2022). Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types. Wounds – 3 Citations

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Wild, T., Gethin, G. (2021). Development of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol). Journal of Tissue Viability – 3 Citations

  • Marotz, J., Schulz, T., Seider, S., Wild, T., Siemers, F. (2021). 3D-perfusion analysis of burn wounds using hyperspectral imaging. Burns – 13 Citations

  • Zouboulis, C.C., Wild, T., Zouboulis, V.A., Har-Shai, Y. (2021). Intralesional cryosurgery of keloids: required treatment hold time. British Journal of Dermatology – 7 Citations

Marília Dourado | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Marília Dourado | Medicine and Dentistry | Best Researcher Award

Professora Doutora at Faculdade de Medicina- Universidade de Coimbra, Portugal

Marília de Assunção Rodrigues Ferreira Dourado is an esteemed researcher and professor at the Faculty of Medicine, University of Coimbra. With extensive contributions in palliative care, pain medicine, and oncobiology, she has played a key role in advancing research on symptom control, pharmacological prescriptions, and cost-effectiveness in healthcare. She has authored over 30 peer-reviewed journal articles, 15 book chapters, and 162 conference abstracts, highlighting her dedication to academic excellence. Additionally, she has mentored over 70 master’s and PhD students, fostering the next generation of healthcare researchers.

Professional Profile 

Education

Marília Dourado holds a distinguished academic background in medicine and research. She is a Professor with Aggregation at the Faculty of Medicine, University of Coimbra, and possesses Competence in Experimental Pathology from the Portuguese Medical Association. Her commitment to palliative care education and research is evident through the programs she has established, such as the Master’s in Continuing and Palliative Care and the Postgraduate Program in Pain Medicine.

Professional Experience

With a robust career in academia and research, Marília Dourado is a Professor at the Faculty of Medicine, University of Coimbra, where she teaches and coordinates multiple programs. She established the Center for Studies and Development of Palliative Care (CEDCP) and leads research on biomarkers for pain, symptom control, and caregiver support. She is also an active member of the International Association for Hospice and Palliative Care (IAHPC), contributing to global advancements in palliative medicine.

Research Interest

Marília de Assunção Rodrigues Ferreira Dourado’s research primarily focuses on palliative care, pain medicine, and oncobiology. She has made significant contributions in symptom control, pharmacological prescriptions for end-of-life care, and the cost-effectiveness of palliative treatments. Her work also includes the development and validation of health measurement instruments, ensuring accurate assessment in clinical settings. Additionally, she explores biomarkers for pain diagnosis and treatment, aiming to improve pain management strategies. Her research extends to training and supporting informal caregivers, emphasizing the importance of holistic care in palliative settings.

Awards and Honors

Marília Dourado has been recognized for her contributions to medical research, education, and healthcare innovation. She has received accolades for her work in palliative care development, research excellence, and academic leadership. Her role in creating and coordinating specialized programs has earned her professional recognition both nationally and internationally. As a member of the International Association for Hospice and Palliative Care (IAHPC), she continues to influence the field globally.

Research Skills

Marília Dourado possesses a diverse set of research skills spanning clinical research, health assessment methodologies, and pharmacological studies. She specializes in qualitative and quantitative research methods, systematic reviews, and clinical trial design. Her expertise includes biomarker identification for pain, validation of health measurement instruments, and cost-effectiveness analysis in palliative care. Additionally, she is adept at mentoring researchers, designing curriculum-based research programs, and publishing in high-impact journals. Her interdisciplinary approach enables her to bridge clinical practice with innovative healthcare solutions.

Conclusion

Marília de Assunção Rodrigues Ferreira Dourado is a highly qualified and impactful researcher in palliative care, pain medicine, and oncobiology, making her a strong candidate for the Best Researcher Award. Her leadership in academic programs, research contributions, and mentoring efforts support her candidacy. To further strengthen her position, she could focus on increasing high-impact publications, securing major research grants, and expanding international collaborations.

Publications Top Noted

  • Opioids and Constipation Therapy in the Last Week of Life: Their Impact on Patients, Caregivers, and the Location of Death
    Authors: Ribeiro H, Magalhães J, Cardoso T, Chaves-Castro I, Lopes-Mota C, Costa E, Rocha P, Lopes L, Bouça Â, Pereira C, Dourado M et al.
    Year: 2023
    Citation: Ribeiro H et al., Medicine, 2023, DOI: 10.1097/md.0000000000032718

  • Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
    Authors: Ribeiro H, Alves R, Jorge J, Gonçalves AC, Sarmento-Ribeiro AB, Teixeira-Veríssimo M, Dourado M, Andrade JP
    Year: 2023
    Citation: Ribeiro H et al., Biomedicines, 2023, DOI: 10.3390/biomedicines11020380

  • “Dignity as a Small Candle Flame That Doesn’t Go Out!”: An Interpretative Phenomenological Study with Patients Living with Advanced Chronic Obstructive Pulmonary Disease
    Authors: Laranjeira C, Dourado M
    Year: 2022
    Citation: Laranjeira C & Dourado M, International Journal of Environmental Research and Public Health, 2022, DOI: 10.3390/ijerph192417029

  • Novel Non-Viral Vectors Based on Pluronic® F68PEI with Application in Oncology Field
    Authors: Silva I, Domingues C, Jarak I, Carvalho RA, Cordeiro RA, Dourado M, Veiga F, Faneca H, Figueiras A
    Year: 2022
    Citation: Silva I et al., Polymers, 2022, DOI: 10.3390/polym14235315

  • Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology
    Authors: Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A
    Year: 2022
    Citation: Domingues C et al., ACS Nano, 2022, DOI: 10.1021/acsnano.2c00128

  • Apoptosis and (in) Pain-Potential Clinical Implications
    Authors: Ribeiro H, Sarmento-Ribeiro AB, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicines, 2022, DOI: 10.3390/biomedicines10061255

  • Prescription Trends at the End of Life in a Palliative Care Unit: Observational Study
    Authors: Peralta T, Castel-Branco MM, Reis-Pina P, Figueiredo IV, Dourado M
    Year: 2022
    Citation: Peralta T et al., BMC Palliative Care, 2022, DOI: 10.1186/s12904-022-00954-z

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain and Aging: Adjusting Prescription to Patient Features
    Authors: Ribeiro H, Rodrigues I, Napoleão L, Lira L, Marques D, Veríssimo M, Andrade JP, Dourado M
    Year: 2022
    Citation: Ribeiro H et al., Biomedicine & Pharmacotherapy, 2022, DOI: 10.1016/j.biopha.2022.112958

  • The Portuguese Performance Assessment of Self-Care Skills Measure: Validity and Reliability
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2021
    Citation: Ferreira PL et al., OTJR: Occupation, Participation and Health, 2021, DOI: 10.1177/15394492211021309

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Individuals with Disabilities
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-60570/v3

  • Knowledge of Palliative Care Among Medical Students of the University of Coimbra
    Authors: Oliveira S, Santiago LM, Dourado M
    Year: 2020
    Citation: Oliveira S et al., Acta Medica Portuguesa, 2020, DOI: 10.20344/amp.12590

  • Validity and Reliability of the Portuguese-Performance Assessment of Self-Care Skills (P-PASS) for Portuguese Individuals with Disabilities
    Authors: Ferreira PL, Simões AL, Dourado M, Holm MB, Rogers JC
    Year: 2020
    Citation: Ferreira PL et al., Preprint, 2020, DOI: 10.21203/rs.3.rs-53489/v1

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Sheba Medical Center, Israel

Liat Waldman Radinsky is a dedicated physician and academic leader specializing in thrombosis, hemophilia, and internal medicine. She has extensive clinical experience, currently serving as a Senior Physician at Sheba Tel Hashomer, one of Israel’s top medical institutions. Her role as an Academic Clinical Lead at the University of Nicosia reflects her commitment to medical education. With a strong background in patient care, teaching, and community service, she has contributed significantly to the healthcare sector. Additionally, she actively participates in social initiatives, such as volunteering for Holocaust survivors, showcasing her dedication to humanitarian efforts.

Professional Profile 

Education

Liat Waldman Radinsky earned her M.D. from Ben-Gurion University of the Negev (2012-2015), following a B.Sc. in Medical Sciences from the same institution (2009-2012). She has also completed various medical training courses, including ACLS, Point of Care Ultrasound, and Adult Sedation. Her education has equipped her with a strong foundation in medical science and clinical practice.

Professional Experience

Liat has held multiple roles in prestigious medical institutions. She is currently a Senior Physician at the National Hemophilia Center, Sheba Tel Hashomer, and previously completed a Clinical Fellowship in Thrombosis and Hemophilia. Her career includes leadership in internal medicine education at the University of Nicosia, medical residency at Soroka Medical Center, and supervisory roles in physician training. She has also worked as a clinical tutor and teaching assistant, contributing to medical education at Ben-Gurion University.

Research Interest

Liat Waldman Radinsky’s research interests lie in the fields of thrombosis, hemophilia, and internal medicine, with a focus on improving patient care and treatment outcomes. Her work in the National Hemophilia Center at Sheba Tel Hashomer has deepened her understanding of blood disorders and coagulation abnormalities. She is particularly interested in clinical advancements, personalized medicine, and the development of innovative treatment protocols for patients with hematological conditions. Additionally, her role as an Academic Clinical Lead allows her to explore medical education research, aiming to enhance training methodologies for future physicians.

Awards and Honors

Throughout her medical career, Liat Waldman Radinsky has been recognized for her excellence in clinical practice and education. She completed her medical internship and residency with distinction at Soroka Medical Center, a testament to her dedication and outstanding performance. Her role as a clinical tutor with distinction further highlights her expertise in mentoring and teaching. Additionally, she has received various scholarships and recognitions for her contributions to medical training and social initiatives.

Research Skills

Liat possesses a strong set of clinical research skills, including patient data analysis, medical diagnostics, and evidence-based medicine application. She is experienced in conducting clinical assessments, applying advanced imaging techniques, and utilizing medical research methodologies to enhance treatment protocols. Her expertise in point-of-care ultrasound and adult sedation procedures further complements her research capabilities. Additionally, her proficiency in multiple languages enables her to collaborate effectively in multinational research projects, broadening her academic and clinical impact.

Conclusion

Liat Waldman Radinsky has an impressive medical and academic background, making her a strong candidate for clinical and educational awards. However, to be highly competitive for the Best Researcher Award, she should focus on publishing high-impact research, securing grants, and demonstrating innovation in her field. If she strengthens these aspects, she would be a more fitting recipient of the award.

Publications Top Noted

Title: Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

Authors: Omri Cohen, Liat Waldman Radinsky, Gili Kenet, Isabelle Mahé, Giovanni Barillari, Silvia Soler, Patricia Sigüenza, María Del Valle Morales, Paula Villares, Manuel Monreal

Year: 2024

Citation: Cohen O, Waldman Radinsky L, Kenet G, Mahé I, Barillari G, Soler S, Sigüenza P, Morales MDV, Villares P, Monreal M. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia. Blood Advances. 2024; DOI: 10.1182/bloodadvances.2024012611.

Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional Profile 

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

  • It Is Not All about Alkaloids—Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.3390/plants13162208

  • Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.1002/cbdv.202400159

  • Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
    Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. Mailänder, Iris Klaiber, Sven Nicolay, Manuel Garcia-Käufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
    Year: 2023
    DOI: 10.3390/fermentation9020190

  • Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
    Authors: Lilo K. Mailänder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2022
    DOI: 10.3390/molecules27238508

  • Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
    Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/plants10061219

  • Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
    Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/pr9050853

  • Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
    Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2021
    DOI: 10.3390/molecules26061530

  • Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000485

  • Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000788

 

José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Published on by Global Scholar Awards

Dr. José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, Brazil 

Dr. José Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereira’s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional Profile 

Education

Dr. José Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e Educação em Saúde de São Paulo (IPES) and Family Health at Universidade Estácio de Sá. Demonstrating a commitment to continuous learning, he is currently pursuing two master’s degrees—one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. José Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das Clínicas in Recife and at Clínica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in Jaboatão dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. José Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. José Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. José Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

José Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: José Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima Cândido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: José Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: José Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: José Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, Ícaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana Macêdo Militão Mendonça, Marília de Brito Ricarte, Luciano Pamplona de Góes Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. Vilá, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Published on by Global Scholar Awards

Dr. Passolguewinde delphine Napon – Zongo | Medicine and Dentistry | Women Researcher Award

Assistante hospitalo-Universitaire en Hépato Gastroentérologie at Institut superieur des sciences de la sante / universite nazi boni, Burkina faso

Dr. Passolguewindé Delphine ZONGO is a dedicated researcher and lecturer at Université Nazi Boni (UNB) in Burkina Faso, specializing in hepatology and gastroenterology. She holds a Doctorate in Medicine, a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, and a Master’s in Public Health (Nutrition & Public Health). Her research focuses on digestive diseases, liver disorders, and public health challenges prevalent in Africa, including hepatitis, NSAID-induced gastrointestinal conditions, and hepatic steatosis. She has published extensively in high-impact journals and collaborates with international institutions such as Université Pierre et Marie Curie in France. Passionate about medical education and research, she actively mentors young scientists and contributes to healthcare improvements in Burkina Faso. Her expertise, commitment to advancing medical knowledge, and impact on public health make her a notable figure in the medical community and a strong candidate for recognition in research and healthcare leadership.

Professional Profile 

Education

Dr. Passolguewindé Delphine ZONGO has an extensive educational background in medicine, specializing in hepatology and gastroenterology. She earned her Doctorate in Medicine from Université Joseph KI-ZERBO in Burkina Faso, where she developed a strong foundation in clinical practice and medical research. She further pursued a Diplôme d’Études Spécialisées (DES) in Hepato-Gastroenterology, enhancing her expertise in digestive and liver diseases. To complement her medical specialization, she obtained a Master’s degree in Public Health with a focus on Nutrition and Public Health, equipping her with the knowledge to address broader healthcare challenges. Her academic journey includes collaborations with prestigious institutions, such as Université Pierre et Marie Curie in France, where she deepened her research skills. Her multidisciplinary education enables her to integrate clinical medicine, research, and public health interventions, making her a leading expert in digestive diseases and a valuable contributor to medical education and healthcare advancement in Burkina Faso.

Professional Experience

Dr. Passolguewindé Delphine ZONGO has built an impressive career in hepatology and gastroenterology, contributing significantly to clinical practice, research, and medical education. She serves as a specialist in hepatology and gastroenterology, diagnosing and treating digestive and liver diseases with a focus on improving patient outcomes. In addition to her clinical work, she is actively involved in medical research, particularly in public health and nutrition, addressing key healthcare challenges in Burkina Faso and beyond. Dr. ZONGO has collaborated with prestigious institutions and contributed to academic publications, reinforcing her expertise in digestive health. She also plays a vital role in medical education, mentoring and training future healthcare professionals. Her experience extends to public health initiatives aimed at raising awareness and improving digestive disease prevention strategies. Through her dedication to patient care, research, and education, Dr. ZONGO continues to make a lasting impact in the medical community, particularly in hepatology and gastroenterology.

Research Interest

Dr. Passolguewindé Delphine ZONGO’s research interests focus on hepatology, gastroenterology, public health, and nutrition, with a particular emphasis on liver diseases and digestive disorders. She is dedicated to studying the epidemiology, diagnosis, and management of liver conditions, including hepatitis, cirrhosis, and metabolic liver diseases. Her work also explores the impact of nutrition on digestive health, aiming to identify dietary factors that influence gastrointestinal diseases. Additionally, Dr. ZONGO is engaged in public health research, addressing healthcare challenges related to digestive diseases in Burkina Faso and other resource-limited settings. She investigates strategies for early detection, prevention, and treatment of gastrointestinal disorders, seeking to improve patient outcomes and healthcare accessibility. Her interdisciplinary approach integrates clinical medicine with public health initiatives, contributing to the development of effective healthcare policies. Through her research, she strives to enhance the understanding of digestive health and promote better disease prevention and management strategies.

Award and Honor

Dr. Passolguewindé Delphine ZONGO has received numerous awards and honors in recognition of her outstanding contributions to hepatology, gastroenterology, and public health research. Her work in liver diseases and digestive health has earned her prestigious accolades from national and international medical organizations. She has been honored for her research on the epidemiology and management of liver conditions in resource-limited settings, receiving grants and fellowships that support her groundbreaking studies. Dr. ZONGO’s commitment to advancing healthcare accessibility and improving patient outcomes has also been acknowledged through various excellence awards in medical research and public health initiatives. She has been invited as a keynote speaker at global conferences, where she shares her expertise with the scientific community. Her dedication to medical education and mentorship has further been recognized with awards for leadership and academic excellence. These honors reflect her significant impact on medical research, education, and healthcare improvement.

Research Skill

Dr. Passolguewindé Delphine ZONGO possesses exceptional research skills, particularly in the fields of hepatology, gastroenterology, and public health. She is highly proficient in designing and conducting epidemiological studies, clinical research, and health data analysis. Her expertise extends to advanced statistical methods, biostatistics, and the application of qualitative and quantitative research techniques to investigate liver diseases and digestive disorders. Dr. ZONGO excels in systematic literature reviews, data interpretation, and evidence-based medical research, enabling her to contribute valuable insights to global healthcare challenges. She has strong skills in grant writing, securing research funding, and collaborating with multidisciplinary teams for large-scale medical studies. Her ability to translate research findings into actionable public health policies demonstrates her commitment to improving healthcare systems. Additionally, she is adept at publishing high-impact research articles and presenting her findings at international conferences, reinforcing her influence as a leading researcher in her field.

Conclusion

Dr. Passolguewindé Delphine ZONGO is a highly qualified candidate for the Best Researcher Award. Her expertise in hepatology, gastroenterology, and public health, along with a strong publication record, makes her a strong contender. To further enhance her competitiveness, she could expand her research leadership, seek more funding, and increase her global collaborations.

Publication Top Noted

Title: Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross-Sectional Study
Authors: D. Napon-Zongo, Delphine; J. Diendéré, Jeoffray; A.M. Sanou, Armel Moumouni; A.N. Zèba, Augustin Nawidimbasba; S. Kouanda, Sèni
Year: 2024
Citations: 0

Jian Zhou | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Jian Zhou | Medicine and Dentistry | Best Researcher Award

Zhongshan hospital, fudan university, China

Dr. Jian Zhou is an Associate Chief Physician in the Department of Orthopedics at Zhongshan Hospital, Fudan University, specializing in spinal surgery, minimally invasive techniques, and bone defect repair. With a Ph.D. in Orthopedics and over a decade of experience, he has led multiple national and provincial research projects, securing competitive grants such as the National Natural Science Foundation of China Youth Fund. His research has resulted in numerous high-impact SCI-indexed publications and several patented innovations in orthopedic surgery. Recognized with prestigious awards, including the National Science and Technology Progress Award, Dr. Zhou is also actively involved in professional committees and serves as an AO Spine Young Faculty. His contributions to orthopedic advancements, particularly in biomaterials and surgical techniques, have significantly influenced spinal surgery practices. While his impact is well-established in China, expanding global collaborations and publishing in top-tier international journals could further enhance his research influence worldwide.

Professional Profile 

Education

Dr. Jian Zhou obtained his Bachelor of Clinical Medicine degree from China Medical University in 2006, laying a strong foundation in medical sciences. He then pursued a Ph.D. in Orthopedics at Zhongshan Hospital, Fudan University, from 2006 to 2011, where he specialized in spinal surgery, minimally invasive techniques, and bone defect repair. His doctoral research focused on innovative orthopedic treatments, particularly in biomaterials and regenerative medicine. Throughout his academic journey, Dr. Zhou demonstrated exceptional research capabilities, earning recognition for his contributions to orthopedic advancements. His education provided him with in-depth expertise in both basic and clinical research, enabling him to develop novel surgical techniques and therapeutic approaches for spinal disorders. His academic excellence was further acknowledged through prestigious awards, including Fudan University’s Outstanding Dissertation Award and Academic Star recognition, solidifying his reputation as a dedicated researcher and clinician in the field of orthopedic surgery.

Professional Experience

Dr. Jian Zhou has built a distinguished career in orthopedic surgery at Zhongshan Hospital, Fudan University. He began as a Resident Physician in the Department of Surgery in 2011 before transitioning to the Department of Orthopedics in 2012. In 2013, he was promoted to Attending Physician, where he gained extensive experience in spinal surgery, minimally invasive techniques, and bone defect repair. His dedication and expertise led to his appointment as an Associate Chief Physician in 2018, a role in which he continues to advance surgical innovations and mentor young medical professionals. Over the years, Dr. Zhou has played a crucial role in pioneering new surgical methods, securing research funding, and contributing to national and international orthopedic advancements. His professional journey reflects a commitment to excellence in patient care, medical research, and academic leadership, making him a recognized figure in the field of spinal and orthopedic surgery.

Research Interest

Dr. Jian Zhou’s research interests focus on spinal surgery, minimally invasive spine techniques, and bone defect repair, integrating both basic and clinical research to develop innovative orthopedic treatments. He has dedicated his work to advancing biomaterials for bone regeneration, particularly in the development of antibiotic-eluting bone substitutes and nano-silver composite scaffolds for infected bone defects. His research also explores tumor-related spinal conditions, including surgical strategies for spinal metastases and optimizing blood loss management in complex spinal procedures. Through various national and provincial research grants, Dr. Zhou has contributed significantly to orthopedic biomaterial innovation, helping improve patient outcomes in spinal reconstruction and fracture healing. His work extends to tissue engineering and regenerative medicine, where he investigates novel approaches to enhance spinal fusion and cartilage repair. With numerous high-impact publications and patents, Dr. Zhou continues to push the boundaries of orthopedic research, aiming for safer and more effective surgical solutions.

Award and Honor

Dr. Jian Zhou has received numerous prestigious awards and honors in recognition of his contributions to orthopedic research and innovation. He was awarded the National Science and Technology Progress Award (Second Class) in 2014 and the Shanghai Science and Technology Progress Award (First and Second Class) for his groundbreaking work in spinal surgery and biomaterials. His achievements also include the Shanghai Medical Science and Technology Award and the Science and Technology Award from the Chinese Association for Laboratory Animal Sciences. As a testament to his early academic excellence, he was named a Shanghai Outstanding Graduate and received Fudan University’s Outstanding Dissertation Award. Additionally, he has been recognized as a Shanghai Rising-Star Scholar and a recipient of the Shanghai Outstanding Young Medical Talents Training Program. These accolades highlight his significant impact on orthopedic advancements, reinforcing his status as a leading researcher and clinician in spinal surgery.

Research Skill

Dr. Jian Zhou possesses strong research skills in orthopedic surgery, spinal reconstruction, and biomaterials innovation, combining clinical expertise with cutting-edge scientific inquiry. His ability to design and execute experimental studies is evident in his extensive work on antibiotic-eluting bone substitutes, nano-silver composite scaffolds, and minimally invasive spinal techniques. He has successfully secured and led multiple national and provincial research grants, showcasing his grant-writing proficiency and ability to drive impactful projects. His expertise in biomechanics, tissue engineering, and regenerative medicine enables him to develop novel approaches for bone defect repair and spinal tumor management. Additionally, his contributions to high-impact scientific publications demonstrate his data analysis, manuscript writing, and peer review skills. With several patents for innovative orthopedic devices, Dr. Zhou also excels in translational research, bridging the gap between laboratory discoveries and clinical applications. His comprehensive research skill set solidifies his role as a pioneer in spinal and orthopedic advancements.

Conclusion

Dr. Jian Zhou is a strong candidate for the Best Researcher Award due to his extensive contributions to spinal surgery research, innovative approaches to bone defect repair, and recognition through prestigious awards and grants. While he could enhance his profile through greater international collaborations and higher impact publications, his current credentials make him highly deserving of such an honor.

Publications Top Noted

  • Functional Silver‐Loaded Porous Composite Scaffold for Bone Tissue Bacterial Infection
    Authors: An’nan Hu, Jian Zhou
    Year: 2025
    DOI: 10.1002/anbr.202500004

  • Anterior cervical discectomy and fusion with self-locking standalone cage for the treatment of cervical degenerative disc disease in patients over 80 years
    Authors: Jian Zhou, Hu An, Zhou XG, Dong J
    Year: 2025
    DOI: 10.1186/s10195-025-00820-7

  • Computed Tomography Perfusion Combined With Preoperative Embolization for Reducing Intraoperative Blood Loss in Separation Surgery for Thoracolumbar Metastases
    Authors: Jian Zhou, Yi Zhou, Sheng Qian, Xilei Li, Hong Lin, Jian Dong, Xiaogang Zhou
    Year: 2024
    DOI: 10.1097/brs.0000000000004780

  • Engineering BPQDs/PLGA nanospheres-integrated wood hydrogel bionic scaffold for combinatory bone repair and osteolytic tumor therapy
    Authors: Zhichao Hu, Jiaqi Lu, An’nan Hu, Yongjiang Dou, Sheng Wang, Dihan Su, Wang Ding, Ruixian Lian, Shunyi Lu, Lan Xiao et al.
    Year: 2022
    DOI: 10.1016/j.cej.2022.137269

  • Could self-locking stand-alone cage reduce adjacent-level ossification development after anterior cervical discectomy and fusion?
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Jian Dong, Xiaogang Zhou
    Year: 2020
    DOI: 10.1016/j.jocn.2020.06.014

  • A comparison of a self-locking stand-alone cage and anterior cervical plate for ACDF: Minimum 3-year assessment of radiographic and clinical outcomes
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Xiaogang Zhou, Jian Dong
    Year: 2018
    DOI: 10.1016/j.clineuro.2018.04.033

  • Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold
    Authors: J. Zhou, X. G. Zhou, J. W. Wang, H. Zhou, J. Dong
    Year: 2018
    DOI: 10.1302/2046-3758.71.bjr-2017-0129.r2

  • Anterior decompression and hybrid reconstruction with titanium mesh cage plus plate and self-locking stand-alone cage for the treatment of three-level cervical spondylotic myelopathy
    Authors: Jian Zhou, Xilei Li, Xiaogang Zhou, Hong Lin, Jian Dong
    Year: 2017
    DOI: 10.1016/j.jocn.2017.04.022

  • Tissue-engineered cartilage constructed by a biotin-conjugated anti-CD44 avidin binding technique for the repairing of cartilage defects in the weight-bearing area of knee joints in pigs
    Authors: H. Lin, J. Zhou, L. Cao, H.R. Wang, J. Dong, Z.R. Chen
    Year: 2017
    DOI: 10.1302/2046-3758.65.bjr-2016-0277

  • Biotin‐conjugated anti‐CD44 antibody–avidin binding system for the improvement of chondrocyte adhesion to scaffolds
    Authors: Hong Lin, Jian Zhou, Longxiang Shen, Yuhui Ruan, Jian Dong, Changan Guo, Zhengrong Chen
    Year: 2014
    DOI: 10.1002/jbm.a.34770

  • The controlled release of vancomycin in gelatin/β‐TCP composite scaffolds
    Authors: Jian Zhou, Taolin Fang, Yichao Wang, Jian Dong
    Year: 2012
    DOI: 10.1002/jbm.a.34170